Cargando…
The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic
Since the outbreak of coronavirus disease 2019 (COVID-19) was first identified, the world has vehemently worked to develop treatments and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented speed. Few of the repositioned drugs for COVID-19 have shown tha...
Autores principales: | Won, Jung-Hyun, Lee, Howard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767501/ https://www.ncbi.nlm.nih.gov/pubmed/33371468 http://dx.doi.org/10.3390/ijms21249775 |
Ejemplares similares
-
Can the COVID-19 Pandemic Disrupt the Current Drug Development Practices?
por: Won, Jung-Hyun, et al.
Publicado: (2021) -
Current Status of COVID-19 Therapies and Drug Repositioning Applications
por: Altay, Ozlem, et al.
Publicado: (2020) -
Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020) -
Drug repositioning in cancer: The current situation in Japan
por: Masuda, Takaaki, et al.
Publicado: (2020) -
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
por: Vaz, Elisa Souza, et al.
Publicado: (2023)